“MET-Mediated Drug Resistance in Colorectal Cancer: In Silico Analysis of the Potential of Epicatechin-3-Gallate and Epigallocatechin-3-Gallate as Therapeutic Adjuvants”, IHRJ, vol. 3, no. (1-Supp), pp. 05–16, June 2026, doi: 10.47963/ihrj.v3i(1-Supp).2075.